EP493 Does ultra-staging with immunohistochemistry improve the detection of metastasis in sentinel lymph nodes in endometrial cancer?. (1st November 2019)
- Record Type:
- Journal Article
- Title:
- EP493 Does ultra-staging with immunohistochemistry improve the detection of metastasis in sentinel lymph nodes in endometrial cancer?. (1st November 2019)
- Main Title:
- EP493 Does ultra-staging with immunohistochemistry improve the detection of metastasis in sentinel lymph nodes in endometrial cancer?
- Authors:
- Chaowawanit, W
Campbell, V
Wilson, E
Chetty, N
Perrin, L
Jagasia, N
Barry, S - Abstract:
- Abstract : Introduction/Background: Ultra-staging with immunohistochemistry (IHC) increases the detection of sentinel lymph node metastasis in endometrial cancer. The aims of this study were: To determine the percentage of positive SLN identified on ultra-staging with IHC which were negative on H&E. To determine if the ultra-staging/IHC result altered the prescription of adjuvant therapy. Methodology: 120 women with histologically confirmed endometrial cancer, treated with a minimally invasive hysterectomy, BSO and SLN mapping were included. All mapped SLNs were histopathological confirmed. If no macroscopic metastasis were identified on H&E staining, ultra-staging with IHC was performed. Results: SLNs of 103 patients were included in the histopathological analysis. Ninety eight percent (101/103) of all, had ultra-staging performed. Positive SLNs were identified in 7 cases. Two cases had macroscopic metastasis on H&E staining. Using our ultra-staging protocol, 5 patients (5%) had positive SLNs (3 had microscopic metastasis and 2 had isolated tumour cells). According to the Queensland Centre for Gynaecological Cancer (QCGC) protocol for adjuvant therapy, 14 of 101 patients (14%) had their adjuvant treatment altered based on the SLN status after ultra-staging. Conclusion: Ultra-staging with IHC increased the detection of positive SLNs. Ultra-staging decreased the prescribed adjuvant therapy in 14% of our patients. Disclosure: Nothing to disclose.
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 4
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 4
- Issue Display:
- Volume 29, Issue 4 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 4
- Issue Sort Value:
- 2019-0029-0004-0000
- Page Start:
- A309
- Page End:
- A309
- Publication Date:
- 2019-11-01
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-ESGO.552 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19764.xml